Jimenez aims to keep off-patent Diovan in blockbuster territory - FiercePharma
Links shared publicly online about this topic.
- 94total visits
Jimenez aims to keep off-patent Diovan in blockbuster territory - FiercePharma
Yesterday, we got some hints about Pfizer's post-patent strategy for Lipitor. Novartis ($NVS) CEO Joe Jimenez (photo) is also thinking patents. He's now talking about his company's post-patent plans Read more...
View full resource at fiercepharma.com
Tags: Cholesterol Medication, High Blood Pressure Medication, Lipitor, Diovan, Pfizer, Novartis
Most Recently Shared on August 5, 2011 at 4:24 pm By:
Today, it's the Novartis post-patent strategy for Diovan. http://bit.ly/nCUdXG
Advertisement
